累及肠系膜下动脉的2型内漏的手术治疗
该回顾性研究分析了2005至2015年间901例EVAR患者,其中37例(4.2%)为肠系膜下动脉相关2型内漏,21例接受手术(VLS 11例,TAE 10例)。手术安全,无动脉瘤相关死亡或严重并发症;VLS组囊腔直径更稳定,TAE组住院时间更短;两组再干预率无显著差异。
要点
- IMA相关T2E的手术治疗安全,无动脉瘤相关死亡或严重并发症。
- VLS组囊腔直径稳定,TAE组住院时间更短。
- 两组IMA相关T2E再干预率无显著差异,但二次主动脉再干预率28.6%。
核心结论
- IMA相关T2E的手术治疗是安全的,VLS在封堵此类内漏方面有效且持久。
- EVAR后接受IMA相关T2E纠正的患者仍存在发生任何类型内漏及再干预的风险。
研究设计与样本
- 回顾性分析2005年1月至2015年12月共901例EVAR患者,883例(98%)至少有一次有效术后影像评估。
- 所有因IMA相关T2E接受手术修复的患者纳入最终分析。
主要发现
- 共检测到192例(21.7%)T2E,其中37例(4.2%)为IMA相关T2E,21例接受治疗(VLS 11例,TAE 10例)。
- 无动脉瘤相关死亡或主要/次要并发症。
- 手术时间无显著差异(分钟,VLS 97±46 vs TAE 95±21,P=0.901)。
- TAE组住院时间显著更短(天,4±2 vs 1±0.4,P<0.001)。
- 末次随访时,VLS组囊腔直径更稳定(mm,60±10 vs 55±7,P=0.593),TAE组囊腔直径变化显著(mm,57±9 vs 63±10,P=0.050)。
关键数值与推荐
- 手术指征为囊腔增大(6个月内>5 mm或较术前直径>1 cm,无论术后时间)和/或持续>12个月。
- IMA相关T2E再干预率无显著差异(VLS 0% vs TAE 20.0%,P=0.213)。
- 二次主动脉再干预率为28.6%(6例),二次开放转流率为9.5%(VLS 1例[9.1%] vs TAE 1例[10.0%],P=1)。
临床怎么用
- 对于IMA相关T2E,VLS可有效封堵内漏并使囊腔直径稳定,TAE则住院时间更短。
- 术后需长期随访,警惕任何类型内漏及再干预风险。
局限性
- 回顾性研究,样本量较小(21例治疗患者)。
- 单中心经验,随访时间有限(平均46±32个月)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We report the results of the operative treatment for type 2 endoleak (T2E) involving the inferior mesenteric artery (IMA) using the transarterial embolization (TAE) or the video laparoscopic ligation (VLS). METHODS: Between January 2005 and December 2015, we retrospectively analyzed 901 patients treated with endovascular aortic repair (EVAR): 883 (98%) had 1 valid postoperative radiologic evaluation, at least. All patients with operative repair for IMA-related T2E entered the final analysis. Indication of their operative repair was sac enlargement (>5 mm within 6 months or >1 cm from the preoperative diameter, irrespectively of the postoperational time) and/or its persistence >12 months. RESULTS: We detected 192 (21.7%) T2Es, overall. We identified 37 (4.2%) IMA-related T2Es, and treated 21 cases (VLS n = 11, TAE n = 10). Aneurysm-related mortality and major or minor morbidity was never observed. Time of intervention did not differ significantly (minutes, VLS = 97 ± 46 vs. TAE = 95 ± 21, P = 0.901). Hospitalization was significantly lower in the TAE group (days, 4 ± 2 vs. 1 ± 0.4, P < 0.001). No patient was lost at a mean follow-up of 46 ± 32 months (range, 1-110; median, 48). At last follow-up, sac diameter was significantly more stable in the VLS (mm, 60 ± 10 vs. 55 ± 7, P = 0.593) than that in the TAE group (mm, 57 ± 9 vs. 63 ± 10, P = 0.050). The IMA-related T2E reintervention rate was not significantly different between the groups (VLS, n = 0 [0%] vs. TAE, n = 2 [20.0%], P = 0.213). Secondary aortic reintervention rate was 28.6% (n = 6), and secondary open conversion rate was 9.5% (VLS, n = 1 [9.1%] vs. TAE, n = 1 [10.0%], P = 1). CONCLUSIONS: In authors' experience, operative treatment of IMA-related T2E was safe; VLS proved to be effective and durable in sealing this type of T2E. Patients receiving correction of IMA-related T2E after EVAR remained at risk for development of any type of endoleaks, as well as at risk of reintervention.
引用
- Piffaretti G, Franchin M, Botteri E, et al. Operative Treatment of Type 2 Endoleaks Involving the Inferior Mesenteric Artery. Ann Vasc Surg. 2016. PMID: 27890832. doi:10.1016/j.avsg.2016.07.072
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。